NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 26, 2025 $1.75 -2.84% $1.75 V 99.94% 10
Jun 26, 2025 $1.77 -1.77% $1.75 V 98.97% 2
Jun 26, 2025 $2.00 +11.11% $1.75 X 85.71% 0
Jun 12, 2025 $1.84 +3.00% $1.84 V 99.80% 6
Jun 12, 2025 $1.82 +1.87% $1.84 V 99.10% 3
Jun 12, 2025 $1.95 +8.94% $1.84 V 94.02% 1
Jun 4, 2025 $2.01 +8.65% $1.91 V 94.76% 1
Jun 3, 2025 $1.71 -3.28% $1.85 X 92.54% 0
Jun 3, 2025 $1.73 -2.05% $1.85 X 93.72% 0
Jun 3, 2025 Bullish $1.85 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE